🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The main purpose of this study is to investigate the Efficacy and Safety of...
Status
Active Not Recruiting
Location
Beijing
Start Date
2025-01-16
Trial ID
NCT06777238
The main purpose of this study is to investigate the Efficacy and Safety of...
Status
Active Not Recruiting
Location
Tianjin Medical University General Hospital
Start Date
2025-02-13
Trial ID
NCT06778967
Treatments Being Tested
This trial is conducted in China. The aim of the trial is to evaluate the s...
Status
Completed
Location
Gan & Lee Pharmaceuticals Co., Ltd
Start Date
2021-12-02
Trial ID
NCT06548997
This is a multicenter, randomized, open-label, positive controlled efficacy...
Status
Active Not Recruiting
Location
Study site 01
Start Date
2025-08-07
Trial ID
NCT07055386
This study adopts a multicenter, single-dose, open-label, and parallel desi...
Status
Recruiting
Location
Gan & Lee Pharmaceuticals
Start Date
2025-04-11
Trial ID
NCT07141030
Treatments Being Tested
This is an open-label, randomized, single-dose, parallel comparison bioequi...
Status
Recruiting
Location
The Second Affiliated Hospital of Soochow University
Start Date
2026-01-09
Trial ID
NCT07355738
Treatments Being Tested
The study is a multicenter, randomized, double-blind, parallel-group, place...
Status
Not Yet Recruiting
Location
Gan & Lee Pharmaceuticals
Start Date
2026-03-27
Trial ID
NCT07501832
Treatments Being Tested
This study is a multicenter, randomized, open-label, parallel-group phase I...
Status
Recruiting
Location
Beijing
Start Date
2025-09-23
Trial ID
NCT07150975
Treatments Being Tested
This trial is a randomized, double-blind, three-period crossover Phase I Cl...
Status
Not Yet Recruiting
Location
Study site 01
Start Date
2025-05-08
Trial ID
NCT06974487
Treatments Being Tested
This is a randomized, double-blind, placebo-controlled Phase Ib/IIa clinica...
Status
Completed
Location
Gan & Lee Pharmaceuticals Co., Ltd
Start Date
2022-06-29
Trial ID
NCT06256523